General
Preferred name
FENOLDOPAM MESYLATE
Synonyms
SKF-82526 mesylate ()
Fenoldopam methanesulfonate ()
Corlopam mesylate ()
SKF 82526 ()
mesylate ()
Fenoldopam (mesylate) ()
Fenoldopam (methanesulfonate) ()
SKF-82526 (mesylate) ()
SKF 82526 (mesylate), Fenoldopam methanesulfonate, Corlopam mesylate ()
NSC-759860 ()
SK&F-82526J ()
SK-82526-J ()
Corlopam ()
Fenoldopam mesilate ()
Fendolopam mesylate ()
SK&F 82526-J ()
P&D ID
PD000365
CAS
67227-57-0
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Antihypertensive
Dopamine Agonist
First approval
1997
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Cell lines
0
Organisms
2
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
16
Properties
(calculated by RDKit )
Molecular Weight
401.07
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
5
Rotatable Bonds
1
Ring Count
3
Aromatic Ring Count
2
cLogP
2.24
TPSA
127.09
Fraction CSP3
0.29
Chiral centers
1.0
Largest ring
7.0
QED
0.37
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Neuronal Signaling
Apoptosis
GPCR/G protein
Target
dopamine-1 receptor
Dopamine Receptor
Source data